celgene / Celgene: A Global Biopharmaceutical Company Committed to Improving the Lives of Patients Worldwide

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔

Meta Tags

Title	Celgene: A Global Biopharmaceutical Company Committed to Improving the Lives of Patients Worldwide
Description	Celgene gehört jetzt zu Bristol Myers Learn about how Celgene, a global biopharmaceutical company, is committed to improving the lives of patients worldwide by delivering truly innovative and life-changing
Keywords	N/A

Server Information

WebSite	celgene.ch
Host IP	45.60.170.161
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

chlth.net

crystaldigit.com

deepeye.ai

deliverooinsiders.com

synergyglobalitservices.com

celgene.ch Valuation

US$352,264

Last updated: 2022-07-21 14:43:47

celgene.ch has Semrush global rank of 30,046,535. celgene.ch has an estimated worth of US$ 352,264, based on its estimated Ads revenue. celgene.ch receives approximately 40,646 unique visitors each day. Its web server is located in United States, with IP address 45.60.170.161. According to SiteAdvisor, celgene.ch is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$352,264
Daily Ads Revenue	US$326
Monthly Ads Revenue	US$9,755
Yearly Ads Revenue	US$117,060
Daily Unique Visitors	2,710
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
celgene.ch.	A	297	IP: 45.60.170.161
celgene.ch.	A	297	IP: 45.60.150.161
celgene.ch.	NS	86400	NS Record: ns-596.awsdns-10.net.
celgene.ch.	NS	86400	NS Record: ns-1466.awsdns-55.org.
celgene.ch.	NS	86400	NS Record: ns-1675.awsdns-17.co.uk.
celgene.ch.	NS	86400	NS Record: ns-200.awsdns-25.com.
celgene.ch.	MX	300	MX Record: 10 mail.celgene.ch.
celgene.ch.	TXT	300	TXT Record: 8zqn8hxkq6t04jc3h1k23kr27q0dj30q

HtmlToTextCheckTime:2022-07-21 14:43:47

Suche Suche www.celgene.co Senden Switzerland Australia English Austria Deutsch Belgium Français Nederlands Brazil Português Canada English Français Czech Republic Čeština Denmark Dansk Europe English Finland Suomi France Français Germany Deutsch Ireland English Italy Italiano Japan 日本語 Luxembourg Français Nederlands Mexico Español Netherlands Nederlands Norway Norsk Poland Polski Portugal Português Russia Русский язык South Korea 한국어 Spain Español Sweden Svenska Switzerland Deutsch Français Turkey Türk United Kingdom English United States English Deutsch Français Über Uns Compliance Standorte Krankheitsbilder Akute myeloische Leukämie (AML) Myelodysplastische Syndrome (MDS) Multiples Myelom (MM) Mantelzell-Lymphom (MCL) Brustkrebs / Mammakarzinom Bauchspeicheldrüsenkrebs Lungenkrebs Die Psoriasis Die Psoriasis-Arthritis Forschung & Entwicklung Medizinische Innovation Verantwortung Patientenfokus EFPIA – Offenlegung von Zuwendungen Newsroom Investoren Karriere Kontakt Celgene gehört

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Thu, 04 Nov 2021 05:44:41 GMT
Content-Type: text/html; charset=iso-8859-1
Connection: keep-alive
Set-Cookie: AWSALBTG=Qcem21Pf46FDxJHK7qJ0dFYPCbH1Xgl9kW1KHwQU4yjAnW0n479ObHp5tZmm/uJ5OfT6k0WQTrqiZ9eFRneWmhJpiVFLCO81HJF3qz7BuLWkQpfRIYGkFtepkfPZVbsw6D/6qiEUXdCyERn0jdf3Zi6YH4zjaOlvR+G+AwOhFoYeNz4DNy8=; Expires=Thu, 11 Nov 2021 05:44:41 GMT; Path=/
Set-Cookie: AWSALBTGCORS=Qcem21Pf46FDxJHK7qJ0dFYPCbH1Xgl9kW1KHwQU4yjAnW0n479ObHp5tZmm/uJ5OfT6k0WQTrqiZ9eFRneWmhJpiVFLCO81HJF3qz7BuLWkQpfRIYGkFtepkfPZVbsw6D/6qiEUXdCyERn0jdf3Zi6YH4zjaOlvR+G+AwOhFoYeNz4DNy8=; Expires=Thu, 11 Nov 2021 05:44:41 GMT; Path=/; SameSite=None
Server: Apache
Location: https://celgene.ch/
Cache-Control: max-age=0
Expires: Thu, 04 Nov 2021 05:44:41 GMT
Set-Cookie: AWSALBAPP-0=_remove_; Expires=Thu, 11 Nov 2021 05:44:41 GMT; Path=/
Set-Cookie: AWSALBAPP-1=_remove_; Expires=Thu, 11 Nov 2021 05:44:41 GMT; Path=/
Set-Cookie: AWSALBAPP-2=_remove_; Expires=Thu, 11 Nov 2021 05:44:41 GMT; Path=/
Set-Cookie: AWSALBAPP-3=_remove_; Expires=Thu, 11 Nov 2021 05:44:41 GMT; Path=/
Set-Cookie: visid_incap_2623380=64PXDgNjRq2OwHye/cFcVUlzg2EAAAAAQUIPAAAAAAACPD2uN4c+ebwMOxi/pR8p; expires=Thu, 03 Nov 2022 09:46:14 GMT; HttpOnly; path=/; Domain=.celgene.ch
Set-Cookie: nlbi_2623380=OPx9dWyh/GA8fIXs/x7FmAAAAAAunnstgdArQ+qz/jz9BhJG; path=/; Domain=.celgene.ch
Set-Cookie: incap_ses_512_2623380=lpUfKPMw4jHLmhfyy/0aB0lzg2EAAAAAM1El3hx2+wyq9pBk5UHerw==; path=/; Domain=.celgene.ch
Set-Cookie: ___utmvmBauKpBaZ=vAvAwZXpNWq; path=/; Max-Age=900
Set-Cookie: ___utmvaBauKpBaZ=WlvDVMK; path=/; Max-Age=900
Set-Cookie: ___utmvbBauKpBaZ=UZI
    XCQOUalU: RtM; path=/; Max-Age=900
X-CDN: Imperva
X-Iinfo: 1004-24412996-24413019 NNNN CT(21 -1 0) RT(1636004680602 0) q(0 4 4 0) r(5 5) U6

HTTP/2 301 
date: Thu, 04 Nov 2021 05:44:43 GMT
content-type: text/html; charset=UTF-8
set-cookie: AWSALBTG=W1Otgmsvf11sJo2z3Nq/dXix4a8YiX6d35v2Zo/Fvp391E8dVHJ5PLqZ+n0k2EOKGYWID0PlICCdofKGmIM7hVLMsvHyFE/LhZcCiSBzM1wH7JOtsNj0/kk+OJtgoJFN6EXIYAqM21hQkSM3NfZ7vq2riY3v1wnMGJrlrdkqQckXETmbq08=; Expires=Thu, 11 Nov 2021 05:44:42 GMT; Path=/
set-cookie: AWSALBTGCORS=W1Otgmsvf11sJo2z3Nq/dXix4a8YiX6d35v2Zo/Fvp391E8dVHJ5PLqZ+n0k2EOKGYWID0PlICCdofKGmIM7hVLMsvHyFE/LhZcCiSBzM1wH7JOtsNj0/kk+OJtgoJFN6EXIYAqM21hQkSM3NfZ7vq2riY3v1wnMGJrlrdkqQckXETmbq08=; Expires=Thu, 11 Nov 2021 05:44:42 GMT; Path=/; SameSite=None; Secure
server: Apache
vary: X-Forwarded-Proto,Accept-Encoding
x-redirect-by: WordPress
location: https://www.celgene.ch/de/
cache-control: max-age=0
expires: Thu, 04 Nov 2021 05:44:42 GMT
x-xss-protection: 1; mode=block
set-cookie: AWSALBAPP-0=_remove_; Expires=Thu, 11 Nov 2021 05:44:43 GMT; Path=/
set-cookie: AWSALBAPP-1=_remove_; Expires=Thu, 11 Nov 2021 05:44:43 GMT; Path=/
set-cookie: AWSALBAPP-2=_remove_; Expires=Thu, 11 Nov 2021 05:44:43 GMT; Path=/
set-cookie: AWSALBAPP-3=_remove_; Expires=Thu, 11 Nov 2021 05:44:43 GMT; Path=/
set-cookie: visid_incap_2623380=6SWbbNuQRlyJKMU1y7gOeUpzg2EAAAAAQUIPAAAAAADKOXHT27JPGBGrCqLbH6a2; expires=Thu, 03 Nov 2022 06:49:08 GMT; HttpOnly; path=/; Domain=.celgene.ch
set-cookie: nlbi_2623380=SPjcDy3OaQBlMAPc/x7FmAAAAACR/3eh3xdsRVyVTohqlD6v; path=/; Domain=.celgene.ch
set-cookie: incap_ses_303_2623380=YNY4dUpgU3eHbVVS/Hg0BEtzg2EAAAAAmopZyyIi0Ar9VjTQavpbfw==; path=/; Domain=.celgene.ch
x-cdn: Imperva
x-iinfo: 1012-49194183-49194184 NNNN CT(20 54 0) RT(1636004682249 0) q(0 0 1 0) r(12 12) U6

HTTP/2 200 
date: Thu, 04 Nov 2021 05:44:44 GMT
content-type: text/html; charset=UTF-8
set-cookie: AWSALBTG=yA6risRLUn7geTjt5h9gkv9KMEXzjD8w+ILY2nT9DMGyTC30WDCKd8NOfAnNiyzEqYeOOPmVgKL8sEYX09xGW135R2VWbNNadcBz+v5NSqFUcwNdiu+rNxPgCk8ebbtrvVgX/iQ4OB8V7gDaDAH4PU4+WgipMLRKgEm5wdlUbQgLsh70OnI=; Expires=Thu, 11 Nov 2021 05:44:43 GMT; Path=/
set-cookie: AWSALBTGCORS=yA6risRLUn7geTjt5h9gkv9KMEXzjD8w+ILY2nT9DMGyTC30WDCKd8NOfAnNiyzEqYeOOPmVgKL8sEYX09xGW135R2VWbNNadcBz+v5NSqFUcwNdiu+rNxPgCk8ebbtrvVgX/iQ4OB8V7gDaDAH4PU4+WgipMLRKgEm5wdlUbQgLsh70OnI=; Expires=Thu, 11 Nov 2021 05:44:43 GMT; Path=/; SameSite=None; Secure
server: Apache
link: ; rel="https://api.w.org/"
link: ; rel="alternate"; type="application/json"
link: ; rel=shortlink
x-tec-api-version: v1
x-tec-api-root: https://www.celgene.ch/de/wp-json/tribe/events/v1/
x-tec-api-origin: https://www.celgene.ch/de/
cache-control: max-age=0
expires: Thu, 04 Nov 2021 05:44:43 GMT
x-xss-protection: 1; mode=block
vary: Accept-Encoding
set-cookie: AWSALBAPP-0=_remove_; Expires=Thu, 11 Nov 2021 05:44:44 GMT; Path=/
set-cookie: AWSALBAPP-1=_remove_; Expires=Thu, 11 Nov 2021 05:44:44 GMT; Path=/
set-cookie: AWSALBAPP-2=_remove_; Expires=Thu, 11 Nov 2021 05:44:44 GMT; Path=/
set-cookie: AWSALBAPP-3=_remove_; Expires=Thu, 11 Nov 2021 05:44:44 GMT; Path=/
set-cookie: visid_incap_2623380=K1/bPWWlSMuS38pqkOp5y0pzg2EAAAAAQUIPAAAAAADHtbrX6O4iOpWR6Qvzy/kQ; expires=Thu, 03 Nov 2022 09:46:14 GMT; HttpOnly; path=/; Domain=.celgene.ch
set-cookie: nlbi_2623380=6SBAEmT93hqGUjc3/x7FmAAAAAAkhyXahsmmaKSmvU+ToJHJ; path=/; Domain=.celgene.ch
set-cookie: incap_ses_512_2623380=5A+5blDexQ6Fmxfyy/0aB0tzg2EAAAAAVVfww7vIVpXWlRQ+wFwtDw==; path=/; Domain=.celgene.ch
x-cdn: Imperva
x-iinfo: 5-28789082-28789083 NNNN CT(23 54 0) RT(1636004682894 0) q(0 0 1 0) r(7 7) U6

celgene.ch valuation and analysis